Rare diseases
Investigational molecules
Locations
Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy
NorwayStudy of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy
NorwayStudy on Cyclophosphamide for Patients with Advanced Breast Cancer with TP53 Mutations
NorwayStudy of isatuximab, belantamab mafodotin and dexamethasone combination for patients with relapsed or refractory multiple myeloma
NorwayStudy on Lutetium (177Lu) Zadavotide Guraxetan for Patients with Recurrent Grade 3 and Grade 4 Glioma
NorwayStudy on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients
NorwayLong-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations
NorwayStudy on Decitabine and Drug Combination for Elderly Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
NorwayStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
NorwayStudy on the Effectiveness of Ixazomib, Lenalidomide, and Dexamethasone in Treating Newly Diagnosed Multiple Myeloma in Patients Eligible for Transplant
NorwayStudy on Ticagrelor and Acetylsalicylic Acid for Patients with Acute Coronary Syndrome Undergoing Coronary Artery Bypass Grafting
NorwayStudy on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
